
AC   T00070
XX
ID   T00070
XX
DT   15.10.1992 (created); ewi.
DT   10.04.2015 (updated); jtr.
CO   Copyright (C), QIAGEN.
XX
FA   Pax-5
XX
SY   B-cell specific activator protein; BSAP; BSAP/PAX-5, B-cell Specific Activating Protein; hPax-5; hPax5; Pax-5; PAX5.
XX
OS   human, Homo sapiens
OC   eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates
XX
GE   G003921 PAX5; HGNC: PAX5.
XX
HO   TSAP (sea urchin).
XX
CL   C0017; paired; 3.2.2.2.2.
XX
SF   5 possible isoforms exists [11];
SF   intact paired domain required for recognition of all Pax-5 binding sites [3];
SF   a C-terminally truncated paired domain recognizes a subset of sites [3];
SF   crystal structure of Pax-5/DNA and of ternary complex Pax-5/c-Ets-1/DNA has been solved [8];
SF   beta-hairpin and helix B of N-terminal domain are involved in direct contact with c-Ets-1 [8];
XX
CP   (pro-, pre-, mature B cells), astrocytic tumors [5]; tonsillar B cells (germinal centers and mantle zone) [12].
EX   tonsil,B-lymphocyte,,adult; detectable; Northern blot; RNA (undefined);  [12].
XX
FF   activator [6];
FF   regulator of B cell development [2];
FF   tumor initiation by inhibiting the p53 transcription [5];
FF   acts synergistically and directly interacts with c-Ets-1 [6] [7];
XX
IN   T09205 Id3; human, Homo sapiens.
XX
MX   M00143 V$PAX5_01.
MX   M00144 V$PAX5_02.
MX   M04064 V$PAX5_05.
MX   M04754 V$PAX5_06.
MX   M04765 V$PAX5_07.
MX   M07223 V$PAX5_11.
MX   M03577 V$PAX5_Q6.
MX   M00808 V$PAX_Q6.
XX
BS   R37605.
BS   R57913.
BS   R04285.
BS   R04286.
BS   R38866.
BS   R35731.
BS   R67123.
BS   R67139.
BS   R67140.
BS   R67141.
BS   R24137.
BS   R24138.
BS   R71687.
BS   R37548.
BS   R39327.
BS   R29684.
BS   R41906.
BS   R38791.
BS   R13323.
BS   R28953.
BS   R37616.
BS   R37617.
BS   R04583.
BS   R04584.
BS   R01666.
BS   R01667.
BS   R01662.
BS   R01663.
XX
DR   TRANSPATH: MO000024683.
DR   TRANSCOMPEL: C00239.
DR   UniProtKB: Q02548;
XX
RN   [1]; RE0002744.
RX   PUBMED: 2116362.
RA   Barberis A., Widenhorn K., Vitelli L., Busslinger M.
RT   A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation
RL   Genes Dev. 4:849-859 (1990).
RN   [2]; RE0003103.
RX   PUBMED: 1375324.
RA   Kozmik Z., Wang S., Doerfler P., Adams B., Busslinger M.
RT   The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP
RL   Mol. Cell. Biol. 12:2662-2672 (1992).
RN   [3]; RE0003116.
RX   PUBMED: 8406007.
RA   Czerny T., Schaffner G., Busslinger M.
RT   DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site
RL   Genes Dev. 7:2048-2061 (1993).
RN   [4]; RE0004279.
RX   PUBMED: 1516825.
RA   Adams B., Doerfler P., Aguzzi A., Kozmik Z., Urbanek P., Maurer-Fogy I., Busslinger M.
RT   Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis
RL   Genes Dev. 6:1589-1607 (1992).
RN   [5]; RE0011183.
RX   PUBMED: 8521821.
RA   Stuart E. T., Haffner R., Oren M., Gruss P.
RT   Loss of p53 function through PAX-mediated transcriptional repression
RL   EMBO J. 14:5638-5645 (1995).
RN   [6]; RE0016685.
RX   PUBMED: 8804314.
RA   Fitzsimmons D., Hodsdon W., Wheat W., Maira S. M., Wasylyk B., Hagman J.
RT   Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter.
RL   Genes Dev. 10:2198-2211 (1996).
RN   [7]; RE0016687.
RX   PUBMED: 10022910.
RA   Wheat W., Fitzsimmons D., Lennox H., Krautkramer S. R., Gentile L. N., McIntosh L. P., Hagman J.
RT   The highly conserved beta-hairpin of the paired DNA-binding domain is required for assembly of Pax-Ets ternary complexes.
RL   Mol. Cell. Biol. 19:2231-2241 (1999).
RN   [8]; RE0023824.
RX   PUBMED: 11779502.
RA   Garvie C. W., Hagman J., Wolberger C.
RT   Structural studies of Ets-1/Pax5 complex formation on DNA.
RL   Mol. Cell 8:1267-1276 (2001).
RN   [9]; RE0042428.
RX   PUBMED: 11799127.
RA   Emelyanov A. V., Kovac C. R., Sepulveda M. A., Birshtein B. K.
RT   The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells
RL   J. Biol. Chem. 277:11156-64 (2002).
RN   [10]; RE0047963.
RX   PUBMED: 11134340.
RA   Roberts E. C., Deed R. W., Inoue T., Norton J. D., Sharrocks A. D.
RT   Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding.
RL   Mol. Cell. Biol. 21:524-533 (2001).
RN   [11]; RE0056170.
RX   PUBMED: 15385562.
RA   Robichaud G. A., Nardini M., Laflamme M., Cuperlovic-Culf M., Ouellette R. J.
RT   Human Pax-5 C-terminal isoforms possess distinct transactivation properties and are differentially modulated in normal and malignant B cells.
RL   J. Biol. Chem. 279:49956-49963 (2004).
RN   [12]; RE0035360.
RX   PUBMED: 12052884.
RA   Lin K. I., Angelin-Duclos C., Kuo T. C., Calame K.
RT   Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells.
RL   Mol. Cell. Biol. 22:4771-4780 (2002).
XX
//